Net Income (Quarterly) Chart

View Net Income (Quarterly) for XTLB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Income (Quarterly) Chart
Start Trial

Historical Net Income (Quarterly) Data

View and export this data back to 2009. Start Trial.
Date Value
December 31, 2024 -0.257M
September 30, 2024 -0.5546M
June 30, 2024 -0.7013M
March 31, 2024 0.485M
December 31, 2023 -0.284M
September 30, 2023 -0.215M
June 30, 2023 -0.364M
March 31, 2023 -0.919M
December 31, 2022 -0.748M
September 30, 2022 -0.821M
June 30, 2022 -0.285M
March 31, 2022 0.506M
December 31, 2021 2.095M
September 30, 2021 -0.795M
June 30, 2021 -1.15M
March 31, 2021 0.286M
December 31, 2020 -1.085M
September 30, 2020 -0.9532M
June 30, 2020 -1.115M
March 31, 2020 0.1733M
December 31, 2019 -1.11M
September 30, 2019 -1.257M
June 30, 2019 -2.854M
March 31, 2019 3.874M
December 31, 2018 1.047M
Date Value
September 30, 2018 1.03M
June 30, 2018 0.034M
March 31, 2018 0.875M
December 31, 2017 -0.002M
September 30, 2017 1.586M
June 30, 2017 -1.388M
March 31, 2017 -0.977M
December 31, 2016 -1.205M
September 30, 2016 -0.286M
June 30, 2016 -0.477M
March 31, 2016 -0.577M
December 31, 2015 -2.136M
September 30, 2015 -0.443M
June 30, 2015 -0.427M
March 31, 2015 -0.616M
December 31, 2014 -0.788M
September 30, 2014 -0.568M
June 30, 2014 -0.71M
March 31, 2014 -0.761M
December 31, 2013 -1.812M
September 30, 2013 0.445M
June 30, 2013 -1.244M
March 31, 2013 -1.102M
December 31, 2012 -0.548M
September 30, 2012 -0.15M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (Quarterly) Range, Past 5 Years

View Net Income (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (Quarterly) Benchmarks

View Net Income (Quarterly) Benchmarks
Start Trial
BioLineRx Ltd. -2.581M
Kamada Ltd. 9.262M
Can-Fite BioPharma Ltd. --
Galmed Pharmaceuticals Ltd. -1.91M
Revium Recovery, Inc. -0.584M